📊 Score Breakdown
Offering Ability
90
Cash Runway
0
Float Risk
22
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
21%
🔄 Reverse Split
30%
• 50-day avg $1.67 approaching $1 threshold
💰 Capital Raise
20%
• Active shelf registration ($150M, 332% of market cap)
💹 Market Data
Market Cap$45.25M
Shares Outstanding26.31M
Float19.79M
Cash$2.25M
Debt$263.5K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 37.7% shares (2025Q4 vs prior)
1 institutional holders · 81.6K shares
#1
FNY Investment Advisers, LLC
81.6K shares
📉 Short Interest
Short Interest45.2K
Days to Cover1.0
% of Float0.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Aug 22, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
8-K
8K EVENT
Mar 17, 2026
4
INSIDER TRANSACTION
Mar 02, 2026
8-K
8K EVENT
Feb 27, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BCHT
📊 BCHT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BCHT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.